Market Place
Sourcing Support
Laurus Labs invests in Laurus Bio
09 Dec 2024 //
INDPHARMAPOST
Laurus Labs posts Financial Results Q2 FY 2025
24 Oct 2024 //
PRESS RELEASE
Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
19 Sep 2024 //
PRESS RELEASE
Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad
16 Sep 2024 //
ECONOMICTIMES
Laurus Labs API Facility Passes USFDA Audit With Zero Observations
14 Sep 2024 //
INDPHARMAPOST
Laurus Labs Q1 FY25: ?1,195 Cr Revenue, ?171 Cr EBITDA
25 Jul 2024 //
PRESS RELEASE
Willow Biosciences announces licensing partnership with Laurus Labs
30 May 2024 //
PRESS RELEASE
Willow Partners With Laurus For API Manufacturing And Development
30 May 2024 //
PR NEWSWIRE
FDA hits drugmaker Laurus Synthesis with a 2nd rebuke
28 May 2024 //
FIERCE PHARMA
Laurus Labs CEO confident of strong growth in CDMO business this year
25 May 2024 //
PRESS RELEASE
FDA Issues Untitled letter to Laurus Synthesis
22 May 2024 //
FDA
How Satyanarayana Chava converted Laurus Labs
17 May 2024 //
PRESS RELEASE
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
14 May 2024 //
REUTERS
Laurus` Generic Oseltamivir Phosphate Receives Approval in the U.S.
01 May 2024 //
FDA
Laurus Labs: CDMO business to accelerate from FY26
29 Apr 2024 //
MONEYCONTROL
Laurus Labs: CDMO services key to improved prospects, say analysts
26 Apr 2024 //
PRESS RELEASE
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
25 Apr 2024 //
INDINPHARMAPOST
Laurus Labs forms JV company
16 Apr 2024 //
INDINPHARMAPOST
Laurus` Generic Gabapentin Receives Approval in the U.S.
08 Apr 2024 //
FDA
Laurus Labs inks JV agreement with KRKA, Slovenia
26 Jan 2024 //
INDIAN PHARMA POST
Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
25 Jan 2024 //
INDIAN PHARMA POST
FDA slams trio of Indian drugmakers with Form 483 filings
03 Jan 2024 //
FIERCE PHARMA
FDA Issues Form 483 to Laurus Synthesis Private Limited
28 Dec 2023 //
FDA
Laurus Labs acquires 87.59% stake in Laurus Bio Private
25 Nov 2023 //
INDIAN PHARMA POST
Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
21 Oct 2023 //
INDIAN PHARMA POST
Laurus Labs` Generic Metformin Hydrochloride Receives Approval in the U.S.
05 Oct 2023 //
FDA
Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
19 Jun 2023 //
INDIANPHARMAPOST
Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACT
31 May 2023 //
ECONOMIC TIMES
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility
12 Feb 2023 //
MEDICALDIALOGUE
Laurus Labs slumps to 52-week low as Kotak Institutional Equities downgrades
02 Dec 2022 //
MONEYCONTROL
Laurus Labs takes stake in Ethan Energy India
25 Nov 2022 //
INDIANPHARMAPOST
Laurus Labs gets Form 483 with 1 observation from USFDA
01 Nov 2022 //
BUSINESS-STANDARD
Laurus Labs planning Rs. 2,000 Cr Capex
27 Oct 2022 //
INDIANPHARMAPOST
Laurus Labs Generic Abacavir Sulfate Receives Approval in the U.S.
25 Jul 2022 //
FDA
Laurus Labs Generic Pirfenidone Receives Approval in the U.S.
19 Jul 2022 //
FDA
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
03 May 2022 //
ECONOMIC TIMES
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
02 May 2022 //
ET HEALTH
Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.
21 Mar 2022 //
FDA
Laurus Labs up 8% in two days on purchase orders from global pharma company
11 Feb 2022 //
BUSINESS-STANDARD
Laurus Labs` Generic Canagliflozin Receives Approval in the U.S.
28 Jan 2022 //
FDA
Laurus Labs inks pact with MPP to produce molnupiravir
21 Jan 2022 //
ECONOMIC TIMES
Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy company
19 Nov 2021 //
ECONOMICTIMES
Unitaid, Clinton Health Access Initiative, and Laurus Labs announce agreement
14 Sep 2021 //
PRESS RELEASE
Laurus Labs, Unitaid and CHAI ink agreement for development of HIV medication
14 Sep 2021 //
PHARMABIZ
Laurus Labs hits record high; rallies 17% in 7 days post Q1 results
09 Aug 2021 //
BUSINESS-STANDARD
Laurus Labs gets licence from DRDO to manufacture & market Covid drug 2DG
02 Jul 2021 //
THEHINDU
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy`s at new highs
17 Sep 2020 //
BUSINESS STANDARD
Laurus Labs has gained 3X since we recommended it a year ago. What you do now?
04 Aug 2020 //
MONEYCONTROL
Infosys, HCL Tech, L&T Infotech, Granules, Laurus Labs hit record highs
14 Jul 2020 //
BUSINESSSTANDARD
Laurus Labs falls over 4% on report of block deals worth Rs 673 crore
29 Jun 2020 //
MONEYCONTROL
Laurus Labs under pressure, plunges 10% after multiple block deals
07 May 2020 //
BUSINESS-STANDARD
Rising Pharma & Laurus Labs Partner to Support the University of Minnesota
27 Mar 2020 //
BUSINESSWIRE
Patent for Pharmacyclic`s cancer drug revoked on challenge by Laurus Labs
23 Mar 2020 //
BUSINESS-STANDARD
Laurus Labs gets 3 observations from USFDA for Visakhapatnam facility
22 Nov 2019 //
MONEY CONTROL
Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs
20 Sep 2019 //
BLOOMBERG
Laurus Labs launches generic Lyrica in US to treat neuropathic conditions
22 Jul 2019 //
BUSINESS STANDARD
Buy Laurus Labs; target of Rs 470: Motilal Oswal
06 May 2019 //
MONEYCONTROL
Buy Laurus Labs; target of Rs 470: Motilal Oswal
11 Apr 2019 //
MONEYCONTROL
